Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021 . (10th June 2022)
- Record Type:
- Journal Article
- Title:
- Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021 . (10th June 2022)
- Main Title:
- Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021
- Authors:
- Miller, Maureen J
Himschoot, Austin
Fitch, Natalie
Jawalkar, Sucheta
Freeman, Dane
Hilton, Charity
Berney, Kevin
Guy, Gery P
Benoit, Tina J
Clarke, Kristie E N
Busch, Michael P
Opsomer, Jean D
Stramer, Susan L
Hall, Aron J
Gundlapalli, Adi V
MacNeil, Adam
McCord, Russell
Sunshine, Gregory
Howard-Williams, Mara
Dunphy, Christopher
Jones, Jefferson M - Abstract:
- Abstract: Background: We assess if state-issued nonpharmaceutical interventions (NPIs) are associated with reduced rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as measured through anti-nucleocapsid (anti-N) seroprevalence, a proxy for cumulative prior infection that distinguishes seropositivity from vaccination. Methods: Monthly anti-N seroprevalence during 1 August 2020 to 30 March 2021 was estimated using a nationwide blood donor serosurvey. Using multivariable logistic regression models, we measured the association of seropositivity and state-issued, county-specific NPIs for mask mandates, gathering bans, and bar closures. Results: Compared with individuals living in a county with all three NPIs in place, the odds of having anti-N antibodies were 2.2 (95% confidence interval [CI]: 2.0–2.3) times higher for people living in a county that did not have any of the 3 NPIs, 1.6 (95% CI: 1.5–1.7) times higher for people living in a county that only had a mask mandate and gathering ban policy, and 1.4 (95% CI: 1.3–1.5) times higher for people living in a county that had only a mask mandate. Conclusions: Consistent with studies assessing NPIs relative to COVID-19 incidence and mortality, the presence of NPIs were associated with lower SARS-CoV-2 seroprevalence indicating lower rates of cumulative infections. Multiple NPIs are likely more effective than single NPIs. Abstract : The presence of continuous state-issued nonpharmaceutical interventionsAbstract: Background: We assess if state-issued nonpharmaceutical interventions (NPIs) are associated with reduced rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as measured through anti-nucleocapsid (anti-N) seroprevalence, a proxy for cumulative prior infection that distinguishes seropositivity from vaccination. Methods: Monthly anti-N seroprevalence during 1 August 2020 to 30 March 2021 was estimated using a nationwide blood donor serosurvey. Using multivariable logistic regression models, we measured the association of seropositivity and state-issued, county-specific NPIs for mask mandates, gathering bans, and bar closures. Results: Compared with individuals living in a county with all three NPIs in place, the odds of having anti-N antibodies were 2.2 (95% confidence interval [CI]: 2.0–2.3) times higher for people living in a county that did not have any of the 3 NPIs, 1.6 (95% CI: 1.5–1.7) times higher for people living in a county that only had a mask mandate and gathering ban policy, and 1.4 (95% CI: 1.3–1.5) times higher for people living in a county that had only a mask mandate. Conclusions: Consistent with studies assessing NPIs relative to COVID-19 incidence and mortality, the presence of NPIs were associated with lower SARS-CoV-2 seroprevalence indicating lower rates of cumulative infections. Multiple NPIs are likely more effective than single NPIs. Abstract : The presence of continuous state-issued nonpharmaceutical interventions (mask mandates, gathering bans, and bar closures) are associated with lower severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) incidence. The combined use of nonpharmaceutical intervention (NPI) and seroprevalence data can inform long-term strategic approaches to limiting disease transmission. … (more)
- Is Part Of:
- Clinical infectious diseases. Volume 75(2022)Supplement 2
- Journal:
- Clinical infectious diseases
- Issue:
- Volume 75(2022)Supplement 2
- Issue Display:
- Volume 75, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 75
- Issue:
- 2
- Issue Sort Value:
- 2022-0075-0002-0000
- Page Start:
- S264
- Page End:
- S270
- Publication Date:
- 2022-06-10
- Subjects:
- novel coronavirus -- COVID-19 -- SARS-CoV-2 -- seroprevalence -- nonpharmaceutical interventions
Communicable diseases -- Periodicals
616.905 - Journal URLs:
- http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗ - DOI:
- 10.1093/cid/ciac469 ↗
- Languages:
- English
- ISSNs:
- 1058-4838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24365.xml